Standpoint Research Downgrades Quest Diagnostics (DGX) to Hold; Lock In Gains
Tweet Send to a Friend
Standpoint Research downgraded Quest Diagnostics (NYSE: DGX) from Buy to Hold.
Standpoint analyst, Ronnie Moas, says, "DGX reported Q4 on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Standpoint analyst, Ronnie Moas, says, "DGX reported Q4 on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
